Hot Products

8-Hydroxypinoresinol
Catalog No: CFN92432

8-Hydroxypinoresinol has antioxidant activity,it and phillygenin significantly reduce the cell injury by 3-morpholinosydnonimine (SIN-1), a ONOO− generator, may be useful for the therapeutic or preventive applications in treating ONOO−-related diseases.

8-Hydroxypinoresinol diglucoside
Catalog No: CFN95083

Reference standards.

8-Hydroxypinoresinol-4'-O-beta-D-glucopyranoside
Catalog No: CFN95356

8-Methoxykaempferol
Catalog No: CFN92382

Standard reference

8-O-Acetylharpagide
Catalog No: CFN97181

8-O-Acetylharpagide has anti-inflammatory, vasoconstrictor, antibacteria and antiviral activities, it also has a biological activity on isolated smooth muscle preparations from guinea pig. 8-O-Acetylharpagide presents the obvious inhibition on Epstein-Barr virus(EBV) infection, it not only apparently inhibits EBV-VCA,but also alleviates the hyperfunction and effusion of capillary permeability at the early inflammation.

8-O-Acetylshanzhiside methyl ester
Catalog No: CFN98966

8-O-Acetylshanzhiside methyl ester(ND01) has potential against cerebral ischemic injury and experimental myocardial ischemia injury, it can increase angiogenesis and improve functional recovery after stroke. ND01 protects diabetic brain against I/R injury by alleviating diabetic cerebral I/R injury and attenuating blood–brain barrier (BBB) breakdown, and its protective effects may involve HMGB-1 and NF-κB signalling pathway.

8-O-Demethyl-7-O-methyl-3,9-dihydropunctatin
Catalog No: CFN97500

Reference standards.

8-Oxyberberine
Catalog No: CFN92157

Reference standards.

8-Prenyldaidzein
Catalog No: CFN97827

8-Prenyldaidzein has cytotoxic properties against P-388 cells, its IC 50 values 5.82 ug/mL, it also exhibits very high antioxidant activity against DPPH radical scavenging.

8-Prenylkaempferol
Catalog No: CFN92346

8-Prenylkaempferol is an effective agent for attenuating pro-inflammatory NO induction, it may be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-κB and IRF-3 and in part by interfering with IκB degradation which subsequently decreases NF-κB translocation. 8-Prenylkaempferol induces differentiation/maturation of MC3T3-E1 osteoblasts by BMP-2/p38/Runx2 pathways , might be a promising agent for inducing osteogenesis.